1. Home
  2. GNPX vs SCKT Comparison

GNPX vs SCKT Comparison

Compare GNPX & SCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNPX
  • SCKT
  • Stock Information
  • Founded
  • GNPX 2009
  • SCKT 1992
  • Country
  • GNPX United States
  • SCKT United States
  • Employees
  • GNPX N/A
  • SCKT N/A
  • Industry
  • GNPX Biotechnology: Pharmaceutical Preparations
  • SCKT Computer Manufacturing
  • Sector
  • GNPX Health Care
  • SCKT Technology
  • Exchange
  • GNPX Nasdaq
  • SCKT Nasdaq
  • Market Cap
  • GNPX 9.1M
  • SCKT 9.8M
  • IPO Year
  • GNPX 2018
  • SCKT 1995
  • Fundamental
  • Price
  • GNPX $0.23
  • SCKT $1.11
  • Analyst Decision
  • GNPX
  • SCKT
  • Analyst Count
  • GNPX 0
  • SCKT 0
  • Target Price
  • GNPX N/A
  • SCKT N/A
  • AVG Volume (30 Days)
  • GNPX 1.1M
  • SCKT 10.3K
  • Earning Date
  • GNPX 08-12-2025
  • SCKT 07-31-2025
  • Dividend Yield
  • GNPX N/A
  • SCKT N/A
  • EPS Growth
  • GNPX N/A
  • SCKT N/A
  • EPS
  • GNPX N/A
  • SCKT N/A
  • Revenue
  • GNPX N/A
  • SCKT $16,711,520.00
  • Revenue This Year
  • GNPX N/A
  • SCKT $8.62
  • Revenue Next Year
  • GNPX N/A
  • SCKT N/A
  • P/E Ratio
  • GNPX N/A
  • SCKT N/A
  • Revenue Growth
  • GNPX N/A
  • SCKT N/A
  • 52 Week Low
  • GNPX $0.20
  • SCKT $0.91
  • 52 Week High
  • GNPX $3.97
  • SCKT $1.72
  • Technical
  • Relative Strength Index (RSI)
  • GNPX 39.16
  • SCKT 39.93
  • Support Level
  • GNPX $0.25
  • SCKT $1.16
  • Resistance Level
  • GNPX $0.29
  • SCKT $1.21
  • Average True Range (ATR)
  • GNPX 0.02
  • SCKT 0.07
  • MACD
  • GNPX -0.01
  • SCKT -0.01
  • Stochastic Oscillator
  • GNPX 12.22
  • SCKT 30.55

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

About SCKT Socket Mobile Inc.

Socket Mobile Inc is a producer of data capture products. The company's products are integrated into mobile applications used in mobile point of sale (mPOS), commercial services (field workers), asset tracking, manufacturing process and quality control, transportation and logistics (goods tracking and movement), event management (ticketing, entry, access control, and identification), medical and education. The company offers barcode scanning products for both one-dimensional, including imager and laser, and two-dimensional barcode scanning in standard and durable cases. The company's geographical segments are the Americas, Europe, Asia Pacific, and Africa, of which the majority of the revenue is generated from the United States.

Share on Social Networks: